234 related articles for article (PubMed ID: 32533967)
1. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.
Buck ES; Lukas VA; Rubin RS
Urology; 2021 May; 151():31-36. PubMed ID: 32533967
[TBL] [Abstract][Full Text] [Related]
2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
3. Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors.
Zuo SW; Wu H; Shen W
Menopause; 2018 Jul; 25(7):828-836. PubMed ID: 29533365
[TBL] [Abstract][Full Text] [Related]
4. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
5. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients.
Li B; Duan H; Chang Y; Wang S
Pharmacol Res; 2021 Feb; 164():105360. PubMed ID: 33307219
[TBL] [Abstract][Full Text] [Related]
7. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause.
Biehl C; Plotsker O; Mirkin S
Menopause; 2019 Apr; 26(4):431-453. PubMed ID: 30363010
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
10. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721
[TBL] [Abstract][Full Text] [Related]
11. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
Chen YY; Su TH; Lau HH
Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121
[TBL] [Abstract][Full Text] [Related]
12. Preventing urinary tract infections after menopause without antibiotics.
Caretto M; Giannini A; Russo E; Simoncini T
Maturitas; 2017 May; 99():43-46. PubMed ID: 28364867
[TBL] [Abstract][Full Text] [Related]
13. Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.
Stute P; Bertschy S; Birkhaeuser M; Bitzer J; Ging A; Raggi A; Steimann S; Stute V
Climacteric; 2022 Jun; 25(3):246-256. PubMed ID: 34907824
[TBL] [Abstract][Full Text] [Related]
14. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM
World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
[TBL] [Abstract][Full Text] [Related]
15. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA
Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary Syndrome of Menopause.
Shifren JL
Clin Obstet Gynecol; 2018 Sep; 61(3):508-516. PubMed ID: 29787390
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women.
Fox KA; Lokken EM; Reed SD; Rahn DD
Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539
[TBL] [Abstract][Full Text] [Related]
18. Female Pelvic Conditions: Genitourinary Syndrome of Menopause.
Brady PH; Gin GT; Rosenblum E; Wilkinson LD
FP Essent; 2022 Apr; 515():32-42. PubMed ID: 35420405
[No Abstract] [Full Text] [Related]
19. Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.
Mounir DM; Hernandez N; Gonzalez RR
Urology; 2021 May; 151():2-7. PubMed ID: 32966821
[TBL] [Abstract][Full Text] [Related]
20. Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.
Sussman TA; Kruse ML; Thacker HL; Abraham J
J Oncol Pract; 2019 Jul; 15(7):363-370. PubMed ID: 31291563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
